BLMH Antikörper (Middle Region)
-
- Target Alle BLMH Antikörper anzeigen
- BLMH (Bleomycin Hydrolase (BLMH))
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human, Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BLMH Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- BLMH antibody was raised against the middle region of BLMH
- Aufreinigung
- Affinity purified
- Immunogen
- BLMH antibody was raised using the middle region of BLMH corresponding to a region with amino acids EYLSNMVGGRKTLYNNQPIDFLKKMVAASIKDGEAVWFGCDVGKHFNSKL
- Top Product
- Discover our top product BLMH Primärantikörper
-
anti-Bleomycin Hydrolase (BLMH) (AA 212-242) antibody
BLMH Reaktivität: Human, Ratte, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Bleomycin Hydrolase (BLMH) (AA 356-454) antibodyBLMH Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Bleomycin Hydrolase (BLMH) (AA 356-454) antibodyBLMH Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 4A2 unconjugated
anti-Bleomycin Hydrolase (BLMH) (AA 1-300) antibodyBLMH Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Bleomycin Hydrolase (BLMH) (AA 1-300) antibodyBLMH Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Bleomycin Hydrolase (BLMH) (AA 30-165) antibodyBLMH Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Maus Monoclonal 6# unconjugated
anti-Bleomycin Hydrolase (BLMH) antibodyBLMH Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bleomycin Hydrolase (BLMH) (AA 287-336) antibodyBLMH Reaktivität: Human, Ratte, Maus, Hund, Meerschweinchen, Zebrafisch (Danio rerio), Schwein, Fledermaus, Hamster, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bleomycin Hydrolase (BLMH) (AA 1-455) antibodyBLMH Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Bleomycin Hydrolase (BLMH) (AA 60-268) antibodyBLMH Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
BLMH Blocking Peptide, catalog no. 33R-2825, is also available for use as a blocking control in assays to test for specificity of this BLMH antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BLMH antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- BLMH (Bleomycin Hydrolase (BLMH))
- Andere Bezeichnung
- BLMH (BLMH Produkte)
- Synonyme
- AI035728 antikoerper, Bh antikoerper, Bmh antikoerper, wu:fb13c01 antikoerper, zgc:66261 antikoerper, bh antikoerper, bmh antikoerper, BH antikoerper, BMH antikoerper, bleomycin hydrolase antikoerper, Bleomycin hydrolase antikoerper, bleomycin hydrolase S homeolog antikoerper, BLMH antikoerper, pepC antikoerper, LOC5569945 antikoerper, Apre_0140 antikoerper, Apar_0899 antikoerper, Smon_1289 antikoerper, Kfla_1242 antikoerper, Snas_3912 antikoerper, BLJ_1941 antikoerper, Olsu_1085 antikoerper, PGTDC60_0106 antikoerper, Blmh antikoerper, blmh antikoerper, blmh.S antikoerper
- Hintergrund
- The normal physiological role of BLM hydrolase is unknown, but it catalyzes the inactivation of the antitumor drug BLM (a glycopeptide) by hydrolyzing the carboxamide bond of its B-aminoalaninamide moiety thus protecting normal and malignant cells from BLM toxicity.
- Molekulargewicht
- 52 kDa (MW of target protein)
-
